These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 37891838)

  • 1. Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.
    Pitton Rissardo J; Fornari Caprara AL
    Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity of cardiac
    Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
    J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
    Orimo S; Suzuki M; Inaba A; Mizusawa H
    Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
    Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
    Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.
    Ishibashi K; Saito Y; Murayama S; Kanemaru K; Oda K; Ishiwata K; Mizusawa H; Ishii K
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):3-11. PubMed ID: 19626324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice.
    Skowronek C; Zange L; Lipp A
    Front Neurol; 2019; 10():152. PubMed ID: 30863360
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Sakuramoto H; Fujita H; Suzuki K; Matsubara T; Watanabe Y; Hamaguchi M; Hirata K
    Clin Park Relat Disord; 2020; 2():20-24. PubMed ID: 34316615
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Catalan M; Dore F; Polverino P; Bertolotti C; Sartori A; Antonutti L; Cucca A; Furlanis G; Capitanio S; Manganotti P
    Mov Disord Clin Pract; 2021 Jul; 8(5):717-724. PubMed ID: 34295947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
    Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
    Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Protocol and Clinical Usefulness of
    Chun IK
    Nucl Med Mol Imaging; 2023 Jun; 57(3):145-154. PubMed ID: 37187951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
    Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
    J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.
    Ryu DW; Kim JS; Lee JE; Oh YS; Yoo SW; Yoo IR; Lee KS
    Clin Nucl Med; 2019 Apr; 44(4):282-288. PubMed ID: 30589669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson's disease.
    Li S; Yue L; Chen S; Wu Z; Zhang J; Hong R; Xie L; Peng K; Wang C; Lin A; Jin L; Guan Q
    Front Aging Neurosci; 2022; 14():1066331. PubMed ID: 36711204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.